Back
Byline Bancorp Vs. Corcept Therapeutics Industry Stock Comparison
Buy
80
BY
Byline Bancorp
Last Price:
31.93
Seasonality Move:
7.48%
Buy
86
CORT
Corcept Therapeutics
Last Price:
57.76
Seasonality Move:
4.71%
Buy
80
Byline Bancorp (BY)
is a Buy
Is Byline Bancorp a Buy, Sell or Hold?
- The current Byline Bancorp [BY] share price is $32.06. The Score for BY is 80, which is 60% above its historic median score of 50, and infers lower risk than normal.
- BY is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
86
Corcept Therapeutics (CORT)
is a Buy
Is Corcept Therapeutics a Buy, Sell or Hold?
- The current Corcept Therapeutics [CORT] share price is $59.12. The Score for CORT is 86, which is 72% above its historic median score of 50, and infers lower risk than normal.
- CORT is currently trading in the 80-90% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk levels may be considerably lower than normal.
BY Stock Price Chart
What is Byline Bancorp's stock price today?
-
The Byline Bancorp share price today is $32.06
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and BY is experiencing slight buying pressure.
CORT Stock Price Chart
What is Corcept Therapeutics's stock price today?
-
The Corcept Therapeutics share price today is $59.12
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CORT is experiencing slight buying pressure.
BY Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.16 | Buy |
| Relative Strength Index (14 RSI): | 71.72 | Buy |
| Chaikin Money Flow: | 48040 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (25.32 - 29.14) | Buy |
| Bollinger Bands (100): | (24.59 - 28.15) | Buy |
CORT Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 3.33 | Buy |
| Relative Strength Index (14 RSI): | 78.53 | Buy |
| Chaikin Money Flow: | 99396 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (45.14 - 52.96) | Buy |
| Bollinger Bands (100): | (31.8 - 46.2) | Buy |
BY Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 29.04 | Buy |
| 20-day SMA: | 27.69 | Buy |
| 50-day SMA: | 26.85 | Buy |
| 200-day SMA: | 24.01 | Buy |
| 8-day EMA: | 29.72 | Buy |
| 20-day EMA: | 28.21 | Buy |
| 50-day EMA: | 27.14 | Buy |
| 200-day EMA: | 24.78 | Buy |
CORT Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 53.25 | Buy |
| 20-day SMA: | 49.96 | Buy |
| 50-day SMA: | 44.55 | Buy |
| 200-day SMA: | 32.18 | Buy |
| 8-day EMA: | 54.41 | Buy |
| 20-day EMA: | 50.72 | Buy |
| 50-day EMA: | 45.72 | Buy |
| 200-day EMA: | 35.55 | Buy |
Byline Bancorp Earnings Growth & BY Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.01 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.14 per share, and a decrease next year of $0.14 per share.
Corcept Therapeutics Earnings Growth & CORT Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.16 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.45 per share, and an increase next year of $0.39 per share.
Byline Bancorp Technical Analysis
| Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 29 | 30 | 31 | 01 | 04 | 05 | 06 | 07 | 08 | 11 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Corcept Therapeutics Technical Analysis
| Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 29 | 30 | 31 | 01 | 04 | 05 | 06 | 07 | 08 | 11 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||